funder-graph › Recipients
Who funds Oxfendazole Development Group
EIN 81-1547477 · Blue Bell, PA · NTEE H80
Oxfendazole Development Group of Blue Bell, PA (EIN 81-1547477) was named as a grant recipient by 4 funders in 6 grants paid totaling $1,804,949 in tax years 2018–2023, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.
Grants received
$1,804,949
6 grants paid
Funders
4
distinct grantmakers
Tax years
2018–2023
as reported by funders
Funders
| Funder | State | Match | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Silicon Valley Community Foundation 20-5205488 | CA | A | 1 | $1,600,000 | 2022 |
| Johns Hopkins University 52-0595110 | MD | A | 1 | $103,372 | 2018 |
| Centre for Effective Altruism USA Inc 47-1988398 | CA | A | 1 | $101,430 | 2022 |
| Amazonsmile Foundation 46-2626883 | WA | B | 3 | $147 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Grants
The 6 most recent grants naming this organization.
| Tax year | Funder | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|---|
| 2023 | Amazonsmile Foundation | Oxfendazole Development Group Blue Bell, PA | B | $43 | paid | GENERAL SUPPORT | 202540919349100629 |
| 2022 | Silicon Valley Community Foundation | Oxfendazole Development Group Blue Bell, PA | A | $1,600,000 | paid | Health | 202333189349318948 |
| 2022 | Centre for Effective Altruism USA Inc | Oxfendazole Development Group Blue Bell, PA | A | $101,430 | paid | DEVELOP THE DEWORMING MEDICINE FOR USE AGAINST HUMAN DWELLING PARASITIC WORMS | 202311339349300516 |
| 2022 | Amazonsmile Foundation | Oxfendazole Development Group Blue Bell, PA | B | $63 | paid | GENERAL SUPPORT | 202313119349100141 |
| 2020 | Amazonsmile Foundation | Oxfendazole Development Group Blue Bell, PA | B | $41 | paid | GENERAL SUPPORT | 202113199349100901 |
| 2018 | Johns Hopkins University | Oxfendazole Development Group Blue Bell, PA | A | $103,372 | paid | SUB-AWARD | 201931349349307448 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.